Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus 0.1% ointment for facial and neck vitiligo in adults
2005-002922-79Phase 4Completed
- Sponsor
- Avemedica
- Start
- Apr 2006
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of Envarsus XR in Vitiligo, sponsored by Avemedica. Primary endpoints: Efficacy of treatment and Safety of treatment. Started Apr 2006; status: completed.
02
Drugs
Envarsus XR
03
Conditions
Vitiligo
Beyond the preview
Go deeper on 2005-002922-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002922-79.